research-funding

Materials scientist and biotechnology founder who directs ARPA-H, the United States agency that funds high-risk, high-reward health research programmes.

A US government health research programme that aims to build one low-cost radiotherapy treatment able to work against cancer that has spread as well as cancer in one place, by combining very fast radiotherapy with materials placed in the tumour that rouse the immune system. It is at the stage of choosing who to fund.

The UK medical research charity for bowel disease: small proof-of-concept grants and PhDs in bowel cancer and inflammatory bowel disease, with patients on its review panels.

Nonprofit executive who leads The V Foundation, a charity that raises money to fund cancer research across the United States.

The US defense department's breast cancer research fund, set aside by Congress every year since 1992. It has received about 4.5 billion dollars and made more than 7,400 awards, with patients helping decide which research is paid for.

An international team, funded in 2026 by Cancer Grand Challenges, that studies people who stay free of cancer against the odds, such as people over 100 and heavy smokers who never get it, to see whether antibodies in their blood help protect them.

Cancer epidemiologist who co-leads KWF, the Dutch Cancer Society, the Netherlands' largest charitable funder of cancer research.

A European Union project, coordinated by the Organisation of European Cancer Institutes, that measured how developed each country's comprehensive cancer centres and networks are and offered training and on-site help, first to countries that had none.

A US National Cancer Institute programme that gathers data on every child, teenager and young adult with cancer into shared resources, and pays for free tumour testing at diagnosis for some childhood cancers so that doctors can choose treatment and trials.

An office of the US defense department that hands out research money which Congress sets aside each year for named diseases. Nine of its programmes are for cancer, among them breast, prostate, ovarian, lung, kidney, pancreatic cancer, melanoma and rare cancers, and patients sit on the panels that choose what is funded.

President and CEO of the Breast Cancer Research Foundation, the largest private funder of breast cancer research worldwide.

A European Union project, coordinated by Portugal's clinical research agency, that helps each country set up a national hub where patients, citizens, researchers and policymakers work together on the EU's cancer research goals.

Systems biologist who has led the Howard Hughes Medical Institute, a major funder of US biomedical and cancer research, since 2016.

A European Union research programme, part of Horizon Europe, with the goal of improving the lives of more than 3 million people affected by cancer by 2030. It pays for projects on understanding cancer, prevention and early detection, diagnosis and treatment, and quality of life.

A European Union project, coordinated by Charité in Berlin, that is building a cancer information website for patients, survivors, families and carers, with a shared library of reviewed content and local versions in ten EU countries.

A European Union project, coordinated by Milan's national cancer institute, that is building and testing a digital questionnaire, designed with patients, to measure the quality of life of people with cancer and survivors in every EU language.

A US National Cancer Institute network, paid for by the Cancer Moonshot, that works to turn lab discoveries about the immune system into better immunotherapy for adults with cancer and into ways of preventing cancer with the immune system.

Norwegian physician and global health leader who has been Chief Executive of Wellcome, one of the world's largest biomedical research funders, since 2024.

Medicinal chemist who led the discovery of the proteasome inhibitor bortezomib and now heads Stand Up To Cancer as President and CEO.

The US defense department's kidney cancer research fund, created by Congress in 2017 with 10 million dollars. It funds work on the biology of kidney cancer, new treatments, patient care and training new researchers.

An international team, funded in 2024 by Cancer Grand Challenges, that is designing tablets which make cancer cells destroy the faulty proteins driving five childhood cancers, proteins that ordinary drugs have not been able to block.

Chief executive of Worldwide Cancer Research, a charity that funds early-stage discovery research into cancer in more than 30 countries.

President of the Champalimaud Foundation in Lisbon, home to the Champalimaud Clinical Centre for cancer care and research.

Chief Executive Officer of the Lustgarten Foundation, the largest private funder of pancreatic cancer research.

The US defense department's lung cancer research fund, with money listed from 2009. It funds work across the whole path of the disease, from causes other than tobacco to screening, brain metastases and life after treatment.

An international team, funded in 2024 by Cancer Grand Challenges, that is collecting huge amounts of data on how immune cells recognise cancer so that a computer can predict it, with the aim of designing immunotherapy for each person's own tumour.

The US defense department's melanoma research fund, created by Congress in 2019. It funds prevention and earlier detection, research on rare melanomas of the eye, hands and feet and mucous membranes, and survivorship, and received 220 million dollars in its first seven years.

The US National Cancer Institute's cloud system that holds cancer research data from many funded studies, from tumour genetics to scans, and lets researchers search and analyse it without downloading it all.

A US National Cancer Institute network, led by Fred Hutch Cancer Center in Seattle, that tests new ways of screening for cancer. Its first study, Vanguard, is checking whether blood tests that look for many cancers at once can be studied properly in a large trial.

Four US research centres, paid for by the National Cancer Institute, that study whether video and phone care can make cancer care better, from screening to life after treatment, including for veterans and for people having care at home.

An international research team, funded in 2019 by Cancer Grand Challenges, that studies how the bacteria and other microbes in the gut are linked to bowel cancer, whether they change how well treatment works, and whether they could be targeted with vaccines or other treatments.

The US defense department's ovarian cancer research fund, started in 1997. It funds work from basic biology to clinical trials, including early detection and survivorship, and has received about 557 million dollars.

A European Union project, coordinated by the Princess Máxima Center in Utrecht, that is writing a European guideline for checking young adult cancer survivors for late effects of treatment and testing it with 1,000 survivors in 11 countries.

The US defense department's pancreatic cancer research fund, created by Congress in 2020. It funds work towards prevention, earlier diagnosis and new treatments, and has made about 100 awards.

A US National Cancer Institute network, started in 2017, that grows patients' tumours in mice to test combinations of cancer drugs before they go into human trials, and shares the models and data with other researchers.

A US defense department research fund that covers a list of cancers Congress names each year, from bladder and blood cancers to sarcoma and thyroid cancer, including several childhood cancers. It has made about 1,180 awards since 2009.

An international team, funded from 2017 by Cancer Grand Challenges, that studied ductal carcinoma in situ, an early change in the breast ducts, to find which cases need treatment and which can safely be watched. Its funding period has ended.

The US defense department's prostate cancer research fund, running since 1997. Congress has given it about 2.4 billion dollars, it has made nearly 4,000 awards, and it puts weight on quality of life, new treatments for lethal disease and the higher rates seen in African American men.

The US defense department's research fund for rare cancers, those affecting six or fewer people in 100,000 a year, created by Congress in 2020. It pays for lab models, new and repurposed treatments, and shared tissue banks, registries and databases for cancers too uncommon to study one centre at a time.

Medicinal chemist who leads The Mark Foundation for Cancer Research, a funder that turns laboratory discoveries into new cancer tests and treatments.

A European Union project, coordinated by the University of Tartu, that is building a shared system so cancer researchers in different countries can analyse each other's data without moving it, starting with childhood, lymphoid, pancreatic, ovarian, lung and prostate cancers.